Page last updated: 2024-10-31

apnea and Wolff-Parkinson-White Syndrome

apnea has been researched along with Wolff-Parkinson-White Syndrome in 1 studies

Apnea: A transient absence of spontaneous respiration.

Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.

Research Excerpts

ExcerptRelevanceReference
"Methylxanthine use in the treatment of apnea of prematurity is well documented."7.69Impact of theophylline use in Wolff-Parkinson-White syndrome. ( Abedin, M; Agwunobi, J; Beeram, M; Sinkford, S; Young, M, 1996)
"Methylxanthine use in the treatment of apnea of prematurity is well documented."3.69Impact of theophylline use in Wolff-Parkinson-White syndrome. ( Abedin, M; Agwunobi, J; Beeram, M; Sinkford, S; Young, M, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agwunobi, J1
Abedin, M1
Young, M1
Beeram, M1
Sinkford, S1

Other Studies

1 other study available for apnea and Wolff-Parkinson-White Syndrome

ArticleYear
Impact of theophylline use in Wolff-Parkinson-White syndrome.
    Journal of the National Medical Association, 1996, Volume: 88, Issue:7

    Topics: Aminophylline; Apnea; Bronchodilator Agents; Cardiotonic Agents; Electrocardiography; Humans; Infant

1996